Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated May 10, 2023, titled "Alembic Pharmaceuticals Limited receives Establishment Inspection Report (EIR) for its Solid Oral Formulation Facility (F-4) at Jarod".
Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated May 10, 2023, titled "Alembic Pharmaceuticals Limited receives Establishment Inspection Report (EIR) for its Solid Oral Formulation Facility (F-4) at Jarod".